AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway-Reference-Cited by-同舟云学术

AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway

Published:2020-07-17 Issue:17 Volume:24 Page:9999-10012
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Zhang Zhan‐Fei¹,Huang Tie‐Jun²,Zhang Xin‐Ke³,Xie Yu‐Jie⁴,Lin Si‐Ting⁵,Luo Fei‐Fei⁵,Meng Dong‐Fang⁵,Hu Hao⁶,Wang Jing⁵,Peng Li‐Xia⁵,Qian Chao‐Nan⁵⁷⁸,Cheng Chao¹,Huang Bi‐Jun⁵^ORCID

Affiliation:

1. Department of Thoracic Surgery The First Affiliated Hospital of Sun Yat‐Sen University Guangzhou China

2. Department of Nuclear Medicine The Second People's Hospital of Shenzhen Shenzhen China

3. Department of Pathology Sun Yat‐Sen University Cancer Center Guangzhou China

4. Department of Thoracic Surgery The People's Hospital of Gaozhou Maoming China

5. Department of Experimental Research State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐Sen University Cancer Center Guangzhou China

6. Department of Traditional Chinese Medicine The First Affiliated Hospital of Sun Yat‐Sen University Guangzhou China

7. Department of Nasopharyngeal Carcinoma Sun Yat‐Sen University Cancer Center Guangzhou China

8. Department of Radiation Oncology Guangzhou Concord Cancer Center Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.15604

Reference52 articles.